Literature DB >> 29141981

Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types.

Je-Keun Rhee1,2, Yu Chae Jung3, Kyu Ryung Kim1,2, Jinseon Yoo1,2, Jeeyoon Kim1,2, Yong-Jae Lee1,2, Yoon Ho Ko4, Han Hong Lee5, Byoung Chul Cho6, Tae-Min Kim7,2.   

Abstract

Surgical archives of tumor specimens are often impure. The presence of RNA transcripts from nontumor cells, such as immune and stromal cells, can impede analyses of cancer expression profiles. To systematically analyze the impact of tumor purity, the gene expression profiles and tumor purities were obtained for 7,794 tumor specimens across 21 tumor types (available in The Cancer Genome Atlas consortium). First, we observed that genes with roles in immunity and oxidative phosphorylation were significantly inversely correlated and correlated with the tumor purity, respectively. The expression of genes implicated in immunotherapy and specific immune cell genes, along with the abundance of immune cell infiltrates, was substantially inversely correlated with tumor purity. This relationship may explain the correlation between immune gene expression and mutation burden, highlighting the need to account for tumor purity in the evaluation of expression markers obtained from bulk tumor transcriptome data. Second, examination of cluster membership of gene pairs, with or without controlling for tumor purity, revealed that tumor purity may have a substantial impact on gene clustering across tumor types. Third, feature genes for molecular taxonomy were analyzed for correlation with tumor purity, and for some tumor types, feature genes representing the mesenchymal and classical subtypes were inversely correlated and correlated with tumor purity, respectively. Our findings indicate that tumor purity is an important confounder in evaluating the correlation between gene expression and clinicopathologic features such as mutation burden, as well as gene clustering and molecular taxonomy. Cancer Immunol Res; 6(1); 87-97. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29141981     DOI: 10.1158/2326-6066.CIR-17-0201

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  42 in total

1.  The cross-talk of cancer-associated fibroblasts assist in prognosis and immunotherapy in patients with breast carcinoma.

Authors:  Xuyu Gu; Shiya Zheng; Haifeng Zhang; Xiaotong Sun; Qin Zhou
Journal:  Cancer Gene Ther       Date:  2022-08-10       Impact factor: 5.854

2.  Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma.

Authors:  Congkuan Song; Zilong Lu; Kai Lai; Donghang Li; Bo Hao; Chenzhen Xu; Shize Pan; Ning Li; Qing Geng
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

3.  Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma.

Authors:  Chengliang Yin; Junyan Zhang; Ming Shen; Zhenyang Gu; Yan Li; Wanguo Xue; Jinlong Shi; Wenrong Huang
Journal:  Front Oncol       Date:  2020-08-20       Impact factor: 6.244

4.  Combination of Immune-Related Genomic Alterations Reveals Immune Characterization and Prediction of Different Prognostic Risks in Ovarian Cancer.

Authors:  Xibo Zhao; Shanshan Cong; Qiuyan Guo; Yan Cheng; Tian Liang; Jing Wang; Guangmei Zhang
Journal:  Front Cell Dev Biol       Date:  2021-04-23

5.  Identification and validation of tumor microenvironment-related genes of prognostic value in lung adenocarcinoma.

Authors:  Jingyan Yuan; Bo Yuan; Lizhong Zeng; Boxuan Liu; Yang Chen; Xia Meng; Ruiying Sun; Xin Lv; Wei Wang; Shuanying Yang
Journal:  Oncol Lett       Date:  2020-06-16       Impact factor: 2.967

6.  Prognostic and Predictive Value of Cadherin 11 for Patients with Gastric Cancer and Its Correlation with Tumor Microenvironment: Results from Microarray Analysis.

Authors:  Zhijun Feng; Xue Li; Zhijian Ren; Jie Feng; Xiaodong He; Chongge You
Journal:  Biomed Res Int       Date:  2020-06-26       Impact factor: 3.411

7.  Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer.

Authors:  Yihao Mao; Qingyang Feng; Peng Zheng; Liangliang Yang; Tianyu Liu; Yuqiu Xu; Dexiang Zhu; Wenju Chang; Meiling Ji; Li Ren; Ye Wei; Guodong He; Jianmin Xu
Journal:  Cancer Manag Res       Date:  2018-09-17       Impact factor: 3.989

Review 8.  Leveraging Single-Cell Approaches in Cancer Precision Medicine.

Authors:  Aritro Nath; Andrea H Bild
Journal:  Trends Cancer       Date:  2021-02-06

9.  CALD1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers.

Authors:  Yixuan Liu; Suhong Xie; Keyu Zhu; Xiaolin Guan; Lin Guo; Renquan Lu
Journal:  Heliyon       Date:  2021-06-09

10.  Chemokine receptor 4 expression is correlated with the occurrence and prognosis of gastric cancer.

Authors:  Yang Li; Hong-Chang Wang; Jin-Shen Wang; Bo Sun; Le-Ping Li
Journal:  FEBS Open Bio       Date:  2020-05-07       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.